Research programme: follicle stimulating hormone modulators - Arena
Latest Information Update: 16 Jul 2016
At a glance
- Originator Arena Pharmaceuticals
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Infertility
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Infertility in USA
- 10 Apr 2006 Preclinical trials in Infertility in USA (unspecified route)